Literature DB >> 11053089

The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function.

F K Chan1.   

Abstract

Signalling by the tumour necrosis factor receptors (TNFR) is thought to be mediated by the binding of the trimeric ligand TNF to three monomeric subunits of the receptor. This ligand induced trimerisation model of TNFR signalling is mainly supported by crystallographic data of the p60 TNFR-1 and TNFbeta complex in which the trimeric ligand interdigitates between the individual receptor chains and prevents the receptor subunits from interacting with each other. Recently, a domain NH(2)-terminal to the ligand binding domain in the extracellular region of p60 TNFR-1, p80 TNFR-2 and Fas was identified that mediates receptor self association before ligand binding. This pre-ligand binding assembly domain or PLAD is critical for assembly of functional receptor complexes on the cell surface and may provide a potential target in the design of future novel therapeutics against diseases mediated by members of the TNFR family of receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053089      PMCID: PMC1766631          DOI: 10.1136/ard.59.suppl_1.i50

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  43 in total

1.  Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.

Authors:  J Mongkolsapaya; J M Grimes; N Chen; X N Xu; D I Stuart; E Y Jones; G R Screaton
Journal:  Nat Struct Biol       Date:  1999-11

2.  Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.

Authors:  R M Siegel; J K Frederiksen; D A Zacharias; F K Chan; M Johnson; D Lynch; R Y Tsien; M J Lenardo
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

3.  Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.

Authors:  S G Hymowitz; H W Christinger; G Fuh; M Ultsch; M O'Connell; R F Kelley; A Ashkenazi; A M de Vos
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

4.  Fluorescence energy transfer measurements on cell surfaces: a critical comparison of steady-state fluorimetric and flow cytometric methods.

Authors:  J Szöllösi; L Trón; S Damjanovich; S H Helliwell; D Arndt-Jovin; T M Jovin
Journal:  Cytometry       Date:  1984-03

5.  Flow cytometric measurement of fluorescence resonance energy transfer on cell surfaces. Quantitative evaluation of the transfer efficiency on a cell-by-cell basis.

Authors:  L Trón; J Szöllósi; S Damjanovich; S H Helliwell; D J Arndt-Jovin; T M Jovin
Journal:  Biophys J       Date:  1984-05       Impact factor: 4.033

6.  A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes.

Authors:  F K Chan; M J Lenardo
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

7.  The receptor for the cytotoxic ligand TRAIL.

Authors:  G Pan; K O'Rourke; A M Chinnaiyan; R Gentz; R Ebner; J Ni; V M Dixit
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

8.  Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity.

Authors:  H Loetscher; R Gentz; M Zulauf; A Lustig; H Tabuchi; E J Schlaeger; M Brockhaus; H Gallati; M Manneberg; W Lesslauer
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

9.  Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor.

Authors:  L A Tartaglia; D V Goeddel
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

10.  Identification of cysteine-rich domains of the type 1 tumor necrosis factor receptor involved in ligand binding.

Authors:  S A Marsters; A D Frutkin; N J Simpson; B M Fendly; A Ashkenazi
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

View more
  15 in total

Review 1.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

2.  Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor.

Authors:  Jill M Kramer; Walter Hanel; Fang Shen; Nilgun Isik; James P Malone; Amarnath Maitra; Wade Sigurdson; David Swart; Joel Tocker; Tian Jin; Sarah L Gaffen
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

Review 3.  Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling.

Authors:  Francis Ka-Ming Chan
Journal:  Cytokine       Date:  2007-04-20       Impact factor: 3.861

Review 4.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Authors:  Fang Shen; Sarah L Gaffen
Journal:  Cytokine       Date:  2008-01-04       Impact factor: 3.861

5.  Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase.

Authors:  Kathryn T Chen; Madhu S Malo; Angela K Moss; Skye Zeller; Paul Johnson; Farzad Ebrahimi; Golam Mostafa; Sayeda N Alam; Sundaram Ramasamy; H Shaw Warren; Elizabeth L Hohmann; Richard A Hodin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-20       Impact factor: 4.052

6.  Expression and purification of a natural N-terminal pre-ligand assembly domain of tumor necrosis factor receptor 1 (TNFR1 PLAD) and preliminary activity determination.

Authors:  Jin Cao; Fang Meng; Xiangdong Gao; Hongxia Dong; Wenbing Yao
Journal:  Protein J       Date:  2011-04       Impact factor: 2.371

7.  Noncompetitive Allosteric Antagonism of Death Receptor 5 by a Synthetic Affibody Ligand.

Authors:  Nagamani Vunnam; Sophia Szymonski; Petra Hirsova; Gregory J Gores; Jonathan N Sachs; Benjamin J Hackel
Journal:  Biochemistry       Date:  2020-09-30       Impact factor: 3.162

8.  Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor.

Authors:  Qingshan Fu; Tian-Min Fu; Anthony C Cruz; Prabuddha Sengupta; Stacy K Thomas; Shuqing Wang; Richard M Siegel; Hao Wu; James J Chou
Journal:  Mol Cell       Date:  2016-02-04       Impact factor: 17.970

9.  Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction.

Authors:  Heather A Huet; Joseph D Growney; Jennifer A Johnson; Jing Li; Sanela Bilic; Lance Ostrom; Mohammad Zafari; Colleen Kowal; Guizhi Yang; Axelle Royo; Michael Jensen; Bruno Dombrecht; Kris R A Meerschaert; Joost A Kolkman; Karen D Cromie; Rebecca Mosher; Hui Gao; Alwin Schuller; Randi Isaacs; William R Sellers; Seth A Ettenberg
Journal:  MAbs       Date:  2014       Impact factor: 5.857

Review 10.  Insights into the biology and therapeutic implications of TNF and regulatory T cells.

Authors:  Benoit L Salomon
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.